PLURISYS

Systems biology approaches to understand cell pluripotency Acronym: PluriSys

Coordinatore	BIOTALENTUM TUDASFEJLESZTO KFT    more  Organization address address: AULICH LAJOS UTCA 26 city: GOEDOELLO postcode: 2100 contact info Nome: Zsuzsanna Cognome: Hericsne Buda Email: send email Telefono: -727 Fax: -761
Nazionalità Coordinatore	Hungary [HU]
Totale costo	3˙842˙833 €
EC contributo	2˙965˙438 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2007-B
Funding Scheme	CP-FP
Anno di inizio	2009
Periodo (anno-mese-giorno)	2009-01-01   -   2012-06-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	BIOTALENTUM TUDASFEJLESZTO KFT  Organization address address: AULICH LAJOS UTCA 26 city: GOEDOELLO postcode: 2100 contact info Nome: Zsuzsanna Cognome: Hericsne Buda Email: send email Telefono: -727 Fax: -761	HU (GOEDOELLO)	coordinator	536˙678.00
2	STICHTING KATHOLIEKE UNIVERSITEIT  Organization address address: GEERT GROOTEPLEIN NOORD 9 city: NIJMEGEN postcode: 6525 EZ contact info Titolo: Mr. Nome: Peter Cognome: Van Woensel Email: send email Telefono: 31243610759	NL (NIJMEGEN)	participant	704˙400.00
3	LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN  Organization address address: GESCHWISTER SCHOLL PLATZ 1 city: MUENCHEN postcode: 80539 contact info Titolo: Prof. Nome: Eckhard Cognome: Wolf Email: send email Telefono: -218076840 Fax: -218076889	DE (MUENCHEN)	participant	392˙000.00
4	KOBENHAVNS UNIVERSITET	DK	participant	364˙000.00
5	INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE  Organization address address: Rue De L'Universite 147 city: PARIS CEDEX 07 postcode: 75338 contact info Titolo: Mr. Nome: Coquet Cognome: Bernard Email: send email Telefono: 33134652032 Fax: 33134652146	FR (PARIS CEDEX 07)	participant	343˙250.00
6	AVANTEA srl  Organization address address: via Cabrini 12 city: Cremona postcode: 26100 contact info Titolo: Prof. Nome: Cesare Cognome: Galli Email: send email Telefono: +39 0372 800329 Fax: +39 0372 800329	IT (Cremona)	participant	328˙000.00
7	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE  Organization address address: The Old Schools, Trinity Lane city: CAMBRIDGE postcode: CB2 1TN contact info Titolo: Ms. Nome: Dawn Cognome: Barker Email: send email Telefono: +44 (0)1223 333543 Fax: +44 (0) 1223 332988	UK (CAMBRIDGE)	participant	297˙110.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The PluriSys project is aimed at increasing the fundamental knowledge of basic biological processes of cell pluripotency and differentiation by generating new holistic data on gene expression and epigenetic modifications associated with cell pluripotency. The project integrates the multidisciplinary excellence in Europe in cell biology, molecular biology and bioinformatics. It also builds on earlier efforts, as consortium partners are leading partners in several EU funded projects in these areas. The PluriSys project links for the first time research activities in different mammalian systems, including murine, porcine and bovine, and in different cell types, from pluripotent cells in pre-implantation embryos, through embryonic stem cells, to epiblast-derived stem cells. Novel bioinformatics approaches and tools will be developed to set common standards for data analyses among all consortium members and, at a wider scale, to provide an integrated data base matching the requirements of systems biologists. Training, education and outreach activities are structured to assure the maximum efficiency in developing and spreading the new standards and to increase the impact of the project for the European Health sector. The project integrates SME partners and academic institutions from 7 countries from all regions of the EU and will help to decrease the fragmentation of ERA. The main impact of the project is expected as integrating efforts in cell biology, cell therapy, molecular biology and bioinformatics for future applications of systems biology on the relevant questions of cell pluripotency and differentiation. Furthermore, the project is expected to yield pracically useful results, such as improved procedures for the derivation, maintenance and differentiation of pluripotent stem cell lines in mouse and large animals, with potential future applications in the fields of regenerative medicine and tissue engineering, and, beyond these areas, in pharmaceutical industry and'